CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 11.56: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.15%
Annual Rate
CNY 0.25Paid annual
Payout Ratio
38.0%Sustainable
Payback Period
86.0 yr
Last Ex-Dividend
Jul 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.42BCNY508.98M · vs all stocks (USD)
Trailing P/E
31.08xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.02BCNY151.92M · vs all stocks (USD)
Profit Margin
10.78%vs Medical Instruments & Supplies peers
52-Week Change
-29.17%vs all stocks
Market Capitalization
3.42BCNY508.98M · vs all stocks (USD)
Enterprise Value
2.69BCNY399.97M · vs all stocks (USD)
Trailing P/E
31.08xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.37xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.26xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.63xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
16.04xvs Medical Instruments & Supplies peers
Gross Margin
25.03%vs Medical Instruments & Supplies peers
Profit Margin
10.78%vs Medical Instruments & Supplies peers
Operating Margin
15.39%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
4.65%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
7.41%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.02BCNY151.92M · vs all stocks (USD)
Revenue per Share (TTM)
6.59CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-1.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
241.66MCNY35.94M · vs all stocks (USD)
EBITDA (TTM)
130.46MCNY19.40M · vs all stocks (USD)
Net Income (TTM)
110.11MCNY16.37M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-4.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
147.92MCNY22.00M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
42.78MCNY6.36M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2500CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.15%vs all stocks
Payout Ratio
38.03%vs Medical Instruments & Supplies peers
Revenue
1.02BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
769.90MCNYFY2025 · Dec 31, 2025Gross Profit
254.48MCNYFY2025 · Dec 31, 2025Operating Income
132.39MCNY19.69M · vs all stocks (USD)
Pre-tax Income
126.38MCNYFY2025 · Dec 31, 2025Income Tax Expense
14.94MCNYFY2025 · Dec 31, 2025Net Income
111.44MCNYFY2025 · Dec 31, 2025EBIT
127.55MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
184.86MCNYFY2025 · Dec 31, 2025Research & Development
40.68MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
33.89MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.47MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.62MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
156.95MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
156.95MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
111.44MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
75.98MCNYFY2025 · Dec 31, 2025Free Cash Flow
8.66MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
762.27MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
111.44MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.52MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-38.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.68MCNYFY2025 · Dec 31, 2025Capital Expenditures
-67.32MCNYFY2025 · Dec 31, 2025Sale of Investments
1.54MCNYFY2025 · Dec 31, 2025Other Investing Activity
-652.50KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-66.43MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-42.12MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.37MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-47.49MCNYFY2025 · Dec 31, 2025Shares Outstanding
156.00MSharesUpdated Aug 21, 2026Float Shares
41.34MSharesUpdated Aug 21, 2026% Held by Insiders
76.11%vs all stocks
% Held by Institutions
0.32%vs all stocks
Total Cash (MRQ)
772.39MCNY114.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.95CNYUpdated Aug 21, 2026Total Debt (MRQ)
19.06MCNY2.83M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0125xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.16xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
9.76CNYUpdated Aug 21, 2026Total Assets
1.71BCNY254.39M · vs all stocks (USD)
Total Current Assets
1.21BCNYFY2025 · Dec 31, 2025Total Liabilities
216.16MCNYFY2025 · Dec 31, 2025Total Non-current Assets
501.01MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
48.98MCNYFY2025 · Dec 31, 2025Total Current Liabilities
167.18MCNYFY2025 · Dec 31, 2025Cash
762.27MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
764.91MCNYFY2025 · Dec 31, 2025Accounts Receivable
244.78MCNYFY2025 · Dec 31, 2025Inventory
167.02MCNYFY2025 · Dec 31, 2025Accounts Payable
123.91MCNYFY2025 · Dec 31, 2025Short-term Debt
5.23MCNYFY2025 · Dec 31, 2025Other Current Liabilities
170.88KCNYFY2025 · Dec 31, 2025Long-term Debt
16.54MCNYFY2025 · Dec 31, 2025Common Stock (Book)
156.00MCNYFY2025 · Dec 31, 2025Retained Earnings
592.31MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.49BCNY222.24M · vs all stocks (USD)
52-Week Low
19.57CNYUpdated Aug 21, 202652-Week High
32.15CNYUpdated Aug 21, 202652-Week Change
-29.17%vs all stocks
50-Day MA
21.34CNYUpdated Aug 21, 2026200-Day MA
25.69CNYUpdated Aug 21, 2026Avg 10-Day Volume
869.41KSharesUpdated Aug 21, 2026Avg 30-Day Volume
928.29KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.7100CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 11.56: safe zoneNotable
Altman Z-Score: 11.56
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Wonik QnC Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Loctek Ergonomic Technology Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Yilida Ventilator Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Qingdao Paguld Intelligent Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Henan Jindan Lactic Acid Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Sunoren Solar Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
DRB-HICOM Berhad
Tier 1ProductionThroughput-Bound ConversionFlowRisk
DKS Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Jiangsu Aoyang Health Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
KraussMaffei Company Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Xinhua Winshare Publishing and Media Co., Ltd.
3 interpretationsPrice Below Mean With Profitability And EquityPrice Below Mean With Profitability And Book ValueCash Elevated Relative to Current Liabilities and Total Assets
Motomotion China Corp.
3 interpretationsPrice Below Mean With Profitability And EquityPrice Below Mean With Profitability And Book ValueCash Elevated Relative to Current Liabilities and Total Assets
Nanjing Comptech Composite Co., Ltd.
3 interpretationsPrice Below Mean With Profitability And EquityPrice Below Mean With Profitability And Book ValueCash Elevated Relative to Current Liabilities and Total Assets